Free Trial

West Bancorporation Inc. Takes Position in Anheuser-Busch InBev SA/NV (NYSE:BUD)

Anheuser-Busch InBev SA/NV logo with Consumer Staples background

West Bancorporation Inc. purchased a new position in shares of Anheuser-Busch InBev SA/NV (NYSE:BUD - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 3,780 shares of the consumer goods maker's stock, valued at approximately $233,000.

A number of other institutional investors have also recently added to or reduced their stakes in BUD. Rakuten Securities Inc. grew its stake in shares of Anheuser-Busch InBev SA/NV by 2,722.7% during the fourth quarter. Rakuten Securities Inc. now owns 621 shares of the consumer goods maker's stock valued at $31,000 after acquiring an additional 599 shares in the last quarter. NBC Securities Inc. purchased a new position in Anheuser-Busch InBev SA/NV in the first quarter valued at about $32,000. Garde Capital Inc. acquired a new stake in Anheuser-Busch InBev SA/NV during the 1st quarter valued at approximately $37,000. Measured Risk Portfolios Inc. acquired a new stake in Anheuser-Busch InBev SA/NV during the 4th quarter valued at approximately $40,000. Finally, ST Germain D J Co. Inc. purchased a new stake in Anheuser-Busch InBev SA/NV during the 1st quarter worth approximately $41,000. 5.53% of the stock is owned by hedge funds and other institutional investors.

Anheuser-Busch InBev SA/NV Stock Performance

BUD stock traded down $0.41 during trading on Friday, hitting $68.93. 1,144,845 shares of the company's stock traded hands, compared to its average volume of 1,983,091. The stock has a market capitalization of $123.88 billion, a price-to-earnings ratio of 19.98, a price-to-earnings-growth ratio of 1.81 and a beta of 0.82. Anheuser-Busch InBev SA/NV has a 52 week low of $45.94 and a 52 week high of $72.13. The stock has a fifty day moving average price of $68.89 and a two-hundred day moving average price of $60.35. The company has a quick ratio of 0.54, a current ratio of 0.70 and a debt-to-equity ratio of 0.80.

Anheuser-Busch InBev SA/NV (NYSE:BUD - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The consumer goods maker reported $0.81 EPS for the quarter, beating the consensus estimate of $0.77 by $0.04. Anheuser-Busch InBev SA/NV had a net margin of 11.74% and a return on equity of 16.09%. Anheuser-Busch InBev SA/NV's revenue for the quarter was down 6.3% on a year-over-year basis. During the same period last year, the firm posted $0.75 earnings per share. As a group, equities analysts anticipate that Anheuser-Busch InBev SA/NV will post 3.37 EPS for the current fiscal year.

Anheuser-Busch InBev SA/NV Increases Dividend

The business also recently announced an annual dividend, which was paid on Friday, June 6th. Shareholders of record on Wednesday, May 7th were paid a $1.0492 dividend. This is an increase from Anheuser-Busch InBev SA/NV's previous annual dividend of $0.87. This represents a yield of 1.2%. The ex-dividend date of this dividend was Wednesday, May 7th. Anheuser-Busch InBev SA/NV's payout ratio is presently 24.64%.

Wall Street Analyst Weigh In

BUD has been the subject of several research analyst reports. Berenberg Bank initiated coverage on Anheuser-Busch InBev SA/NV in a research note on Wednesday, April 2nd. They set a "buy" rating for the company. The Goldman Sachs Group raised shares of Anheuser-Busch InBev SA/NV from a "neutral" rating to a "buy" rating and upped their price target for the company from $70.10 to $88.00 in a report on Monday, May 12th. BNP Paribas raised shares of Anheuser-Busch InBev SA/NV from a "hold" rating to a "strong-buy" rating in a report on Friday, May 30th. Wall Street Zen downgraded shares of Anheuser-Busch InBev SA/NV from a "buy" rating to a "hold" rating in a research report on Sunday, May 18th. Finally, Argus raised shares of Anheuser-Busch InBev SA/NV from a "hold" rating to a "buy" rating and set a $70.00 price target on the stock in a research report on Thursday, March 27th. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and three have given a strong buy rating to the stock. According to MarketBeat.com, Anheuser-Busch InBev SA/NV presently has an average rating of "Buy" and an average price target of $71.50.

Read Our Latest Stock Report on Anheuser-Busch InBev SA/NV

Anheuser-Busch InBev SA/NV Company Profile

(Free Report)

Anheuser-Busch InBev SA/NV produces, distributes, exports, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands.

See Also

Institutional Ownership by Quarter for Anheuser-Busch InBev SA/NV (NYSE:BUD)

Should You Invest $1,000 in Anheuser-Busch InBev SA/NV Right Now?

Before you consider Anheuser-Busch InBev SA/NV, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anheuser-Busch InBev SA/NV wasn't on the list.

While Anheuser-Busch InBev SA/NV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines